| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Dan S Suesskind is Director at TEVA, with reported holdings spanning 2 companies. Dan S Suesskind's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $13.4M at current prices.
Dan S Suesskind's largest disclosed position is in TEVA as Director, worth about $13.3M.
Dan S Suesskind has 3 Form 4 filings on record from January 2018 to September 2026, across 2 companies: Director at Nano-X Imaging (NNOX), 2026; Director at Teva Pharmaceutical Industries (TEVA), 2018.
The 6 reported transactions were 4 open-market purchases and 2 other transactions.
Counted by filing, the open-market trades come to 2 purchases worth about $92K and no sales.
The largest open-market purchase was 50,000 shares of NNOX at an average $0.93 on July 27, 2026, about $47K.